bluuebunny/crossref_metadata_2025_split huggingface dataset:
Outcomes of Patients With Hematologic Malignancies Who Received Inpatient Palliative Care Consultation
Authors: Pasquarella Anthony V. , Islam Shahidul , Ramdhanny Angela , Gendy Mina , Pinto Priya , Braunstein Marc J. 
Published: January 2022

PURPOSE:Palliative care (PC) plays an established role in improving outcomes in patients with solid tumors, yet these services are underutilized in hematologic malignancies (HMs). We reviewed records of hospitalized patients with active HM to determine associations between PC consultation and length of stay, intensive care unit stay, 30-day readmission, and 6-month mortality compared with those who were not seen by PC.METHODS:We reviewed all oncology admissions at our institution between 2013 and 2019 and included patients with HM actively on treatment, stratified by those seen by PC to controls not seen by PC. Groups were compared using Wilcoxon rank-sum, chi-square, and Fisher's exact tests on the basis of the type and distribution of data. Multiple logistic regression models with stepwise variable selection methods were used to find predictors of outcomes.RESULTS:Three thousand six hundred fifty-four admissions were reviewed, among which 370 unique patients with HM were included. Among these, 102 (28%) patients saw PC, whereas the remaining 268 were controls with similar comorbidities. When compared with controls, PC consultation was associated with a statistically significant reduction in 30-day readmissions (16% v 27%; P = .024), increased length of stay (11.5 v 6 days; P < .001), increased intensive care unit admission (28% v 9%; P < .001), and increased 6-month mortality (67% v 15%; P < .001). These data were confirmed in multivariable models.CONCLUSION:In this retrospective study, more than two thirds of patients with HM did not receive PC consultation despite having similar comorbidities, suggesting that inpatient PC consultation is underutilized in patients with HM, despite the potential for decreased readmission rates.
Use of Palliative Care Among Commercially Insured Patients With Metastatic Cancer Between 2001 and 2016
Authors: Ferrario Alessandra , Zhang Fang , Ross-Degnan Dennis , Wharam J. Frank , Twaddle Martha L. , Wagner Anita K. 
Published: January 2022

PURPOSE:Early palliative care, concomitant with disease-directed treatments, is recommended for all patients with advanced cancer. This study assesses population-level trends in palliative care use among a large cohort of commercially insured patients with metastatic cancer, applying an expanded definition of palliative care services based on claims data.METHODS:Using nationally representative commercial insurance claims data, we identified patients with metastatic breast, colorectal, lung, bronchus, trachea, ovarian, esophageal, pancreatic, and liver cancers and melanoma between 2001 and 2016. We assessed the annual proportions of these patients who received services specified as, or indicative of, palliative care. Using Cox proportional hazard models, we assessed whether the time from diagnosis of metastatic cancer to first encounter of palliative care differed by demographic characteristics, socioeconomic factors, or region.RESULTS:In 2016, 36% of patients with very poor prognosis cancers received a service specified as, or indicative of, palliative care versus 18% of those with poor prognosis cancers. Being diagnosed in more recent years (2009-2016 v 2001-2008: hazard ratio [HR], 1.8; P < .001); a diagnosis of metastatic esophagus, liver, lung, or pancreatic cancer, or melanoma ( v breast cancer, eg, esophagus HR, 1.89; P < .001); a greater number of comorbidities (American Hospital Formulary Service classes > 10 v 0: HR, 1.71; P < .001); and living in the Northeast (HR, 1.43; P < .001) or Midwest ( v South: HR, 1.39; P < .001) were the strongest predictors of shorter time from diagnosis to palliative care.CONCLUSION:Use of palliative care among commercially insured patients with advanced cancers has increased since 2001. However, even with an expanded definition of services specified as, or indicative of, palliative care, < 40% of patients with advanced cancers received palliative care in 2016.
Fourth-order exceptional points with spinning resonators
Authors: Qin Haoye , Yin Yiheng , Ding Ming 
Published: January 2022

Abstract
Investigation of exceptional points mostly focuses on the second-order case and employs the gain-involved parity-time (PT) symmetric systems. Here, we propose an approach to implementing fourth-order exceptional points (FOEPs) using directly coupled optical resonators with rotation. On resonance, the system manifests FOEP through tuning the spinning velocity to targeted values. Eigenfrequency bifurcation and enhanced sensitivity for nanoparticle have been presented. Also, near FOEP, nonreciprocal light propagation exhibits great boost and dramatic change, which may be applied to high-efficiency isolators and circulators.
Metabolic Profiling of Obesity With and Without the Metabolic Syndrome: A Multisample Evaluation
Authors: Lind Lars , Salihovic Samira , Sundström Johan , Elmståhl Sölve , Hammar Ulf , Dekkers Koen , Ärnlöv Johan , Smith J Gustav , Engström Gunnar , Fall Tove 
Published: January 2022

Abstract

Context
There is a dispute whether obesity without major metabolic derangements may represent a benign condition or not.

Objective
We aimed to compare the plasma metabolome in obese subjects without metabolic syndrome (MetS) with normal-weight subjects without MetS and with obese subjects with MetS.

Methods
This was a cross-sectional study at 2 academic centers in Sweden. Individuals from 3 population-based samples (EpiHealth, n = 2342, SCAPIS-Uppsala, n = 4985, and SCAPIS-Malmö, n = 3978) were divided into groups according to their body mass index (BMI) and presence/absence of MetS (National Cholesterol Education Program [NCEP]/consensus criteria). In total, 791 annotated endogenous metabolites were measured by ultra-performance liquid chromatography–tandem mass spectrometry.

Results
We observed major differences in metabolite profiles (427 metabolites) between obese (BMI ≥ 30 kg/m2) and normal-weight (BMI &lt; 25 kg/m2) subjects without MetS after adjustment for major lifestyle factors. Pathway enrichment analysis highlighted branch-chained and aromatic amino acid synthesis/metabolism, aminoacyl-tRNA biosynthesis, and sphingolipid metabolism. The same pathways, and similar metabolites, were also highlighted when obese subjects with and without MetS were compared despite adjustment for BMI and waist circumference, or when the metabolites were related to BMI and number of MetS components in a continuous fashion. Similar metabolites and pathways were also related to insulin sensitivity (Matsuda index) in a separate study (POEM, n = 501).

Conclusion
Our data suggest a graded derangement of the circulating metabolite profile from lean to obese to MetS, in particular for metabolites involved in amino acid synthesis/metabolism and sphingolipid metabolism. Insulin resistance is a plausible mediator of this gradual metabolic deterioration.
Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment
Authors: Iwan Katharina , Patel Nina , Heslegrave Amanda , Borisova Mina , Lee Laura , Bower Rebecca , Mole Sara E. , Mills Philippa B. , Zetterberg Henrik , Mills Kevin , Gissen Paul , Heywood Wendy E. 
Published: January 2022

Classic late infantile neuronal ceroid lipofuscinosis (CLN2 disease) is caused by a deficiency of tripeptidyl-peptidase-1. In 2017, the first CLN2 enzyme replacement therapy (ERT) cerliponase alfa (Brineura) was approved by the FDA and EMA. The CLN2 disease clinical rating scale (CLN2 CRS) was developed to monitor loss of motor function, language and vision as well as frequency of generalised tonic clonic seizures. Using CLN2 CRS in an open label clinical trial it was shown that Brineura slowed down the progression of CLN2 symptoms. Neurofilament light chain (NfL) is a protein highly expressed in myelinated axons. An increase of cerebrospinal fluid (CSF) and blood NfL is found in a variety of neuroinflammatory, neurodegenerative, traumatic, and cerebrovascular diseases. We analysed CSF NfL in CLN2 patients treated with Brineura to establish whether it can be used as a possible biomarker of response to therapy. Newly diagnosed patients had CSF samples collected and analysed at first treatment dose and up to 12 weeks post-treatment to look at acute changes. Patients on a compassionate use programme who were already receiving ERT for approximately 1yr had CSF samples collected and NfL analysed over the following 1.3 years (2.3 years post-initiation of ERT) to look at long-term changes. All newly diagnosed patients we investigated with classical late infantile phenotype had high NfL levels >2000 pg/ml at start of treatment. No significant change was observed in NfL up to 12 weeks post-treatment. After one year of ERT, two out of six patients still had high NfL levels, but all patients showed a continued decrease, and all had low NfL levels after two years on ERT. NfL levels appear to correspond and predict improved clinical status of patients on ERT and could be useful as a biomarker to monitor neurodegeneration and verify disease modification in CLN2 patients on ERT.
Low power, less occupying area, and improved speed of a 4-bit router/rerouter circuit for low-density parity-check (LDPC) decoders
Authors: Senthilpari Chinnaiyan , Deena Rosalind , Lini Lee 
Published: January 2022

Background: Low-density parity-check (LDPC) codes are more error-resistant than other forward error-correcting codes. Existing circuits give high power dissipation, less speed, and more occupying area. This work aimed to propose a better design and performance circuit, even in the presence of noise in the channel. Methods: In this research, the design of the multiplexer and demultiplexer were achieved using pass transistor logic. The target parameters were low power dissipation, improved throughput, and more negligible delay with a minimum area. One of the essential connecting circuits in a decoShder architecture is a multiplexer (MUX) and a demultiplexer (DEMUX) circuit. The design of the MUX and DEMUX contributes significantly to the performance of the decoder. The aim of this paper was the design of a 4 × 1 MUX to route the data bits received from the bit update blocks to the parallel adder circuits and a 1 × 4 DEMUX to receive the input bits from the parallel adder and distribute the output to the bit update blocks in a layered architecture LDPC decoder. The design uses pass transistor logic and achieves the reduction of the number of transistors used. The proposed circuit was designed using the Mentor Graphics CAD tool for 180 nm technology. Results: The parameters of power dissipation, area, and delay were considered crucial parameters for a low power decoder. The circuits were simulated using computer-aided design (CAD) tools, and the results depicted a significantly low power dissipation of 7.06 nW and 5.16 nW for the multiplexer and demultiplexer, respectively. The delay was found to be 100.5 ns (MUX) and 80 ns (DEMUX). Conclusion: This decoder’s potential use may be in low-power communication circuits such as handheld devices and Internet of Things (IoT) circuits.
Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients
Authors: Pijls Bart G. , Jolani Shahab , Atherley Anique , Dijkstra Janna I.R. , Franssen Gregor H.L. , Hendriks Stevie , Yi-Wen Yu Evan , Zalpuri Saurabh , Richters Anke , Zeegers Maurice P. 
Published: January 2022

Background: This review aims to investigate the association of sex with the risk of multiple COVID-19 health outcomes, ranging from infection to death. Methods: Pubmed and Embase were searched through September 2020. We considered studies reporting sex and coronavirus disease 2019 (COVID-19) outcomes. Qualitative and quantitative data were extracted using standardised electronic data extraction forms with the assessment of Newcastle Ottawa Scale for risk of bias. Pooled trends in infection, hospitalization, severity, intensive care unit (ICU) admission and death rate were calculated separately for men and women and subsequently random-effects meta-analyses on relative risks (RR) for sex was performed. Results: Of 10,160 titles, 229 studies comprising 10,417,452 patients were included in the analyses. Methodological quality of the included studies was high (6.9 out of 9). Men had a higher risk for infection with COVID-19 than women (RR = 1.14, 95%CI: 1.07 to 1.21). When infected, they also had a higher risk for hospitalization (RR = 1.33, 95%CI: 1.27 to 1.41), higher risk for severe COVID-19 (RR = 1.22, 95%CI: 1.17 to 1.27), higher need for Intensive Care (RR = 1.41, 95%CI: 1.28 to 1.55), and higher risk of death (RR = 1.35, 95%CI: 1.28 to 1.43). Within the period studied, the RR for infection and severity increased for men compared to women, while the RR for mortality decreased for men compared to women. Conclusions: Meta-analyses on 229 studies comprising over 10 million patients showed that men have a higher risk for COVID-19 infection, hospitalization, disease severity, ICU admission and death. The relative risks of infection, disease severity and death for men versus women showed temporal trends with lower relative risks for infection and severity of disease and higher relative risk for death at the beginning of the pandemic compared to the end of our inclusion period. PROSPERO registration: CRD42020180085 (20/04/2020)
Effects of physical activity and dietary supplement on fat free mass and bone mass density during weight loss – a systematic review and meta-analysis.
Authors: Roth Anja , Sattelmayer Martin , Schorderet Chloé , Gafner Simone , Allet Lara 
Published: January 2022

Background: After a diet- or surgery induced weight loss almost 1/3 of lost weight consists of fat free mass (FFM) if carried out without additional therapy. Exercise training and a sufficient supply of protein, calcium and vitamin D is recommended to reduce the loss of FFM. Objective: To investigate the effect of exercise training, protein, calcium, and vitamin D supplementation on the preservation of FFM during non-surgical and surgical weight loss and of the combination of all interventions together in adults with obesity. Methods: A systematic review was performed with a pairwise meta-analysis and an exploratory network meta-analysis according to the PRISMA statement. Results: Thirty studies were included in the quantitative analysis. The pairwise meta-analysis showed for Exercise Training + High Protein vs. High Protein a moderate and statistically significant effect size (SMD 0.45; 95% CI 0.04 to 0.86), for Exercise Training + High Protein vs. Exercise Training a high but statistically not significant effect size (SMD 0.91; 95% CI -0.59 to 2.41) and for Exercise Training alone vs. Control a moderate but statistically not significant effect size (SMD 0.67; 95% CI -0.25 to 1.60). In the exploratory network meta-analysis three interventions showed statistically significant effect sizes compared to Control and all of them included the treatment Exercise Training. Conclusions: Results underline the importance of exercise training and a sufficient protein intake to preserve FFM during weight loss in adults with obesity. The effect of calcium and vitamin D supplementation remains controversial and further research are needed.
Do acetabular parameters measured on 2D imaging correlate with CT, and can lateral centre-edge angle predict femoral head coverage?
Authors: Salih Saif , Grammatopoulos George , Burns Sophia , Hall-Craggs Margaret , Witt Johan 
Published: January 2022

Aims The lateral centre-edge angle (LCEA) is a plain radiological measure of superolateral cover of the femoral head. This study aims to establish the correlation between 2D radiological and 3D CT measurements of acetabular morphology, and to describe the relationship between LCEA and femoral head cover (FHC). Methods This retrospective study included 353 periacetabular osteotomies (PAOs) performed between January 2014 and December 2017. Overall, 97 hips in 75 patients had 3D analysis by Clinical Graphics, giving measurements for LCEA, acetabular index (AI), and FHC. Roentgenographical LCEA, AI, posterior wall index (PWI), and anterior wall index (AWI) were measured from supine AP pelvis radiographs. The correlation between CT and roentgenographical measurements was calculated. Sequential multiple linear regression was performed to determine the relationship between roentgenographical measurements and CT FHC. Results CT-measured LCEA and AI correlated strongly with roentgenographical LCEA ( r = 0.92; p < 0.001) and AI ( r = 0.83; p < 0.001). Radiological LCEA correlated very strongly with CT FHC ( r = 0.92; p < 0.001). The sum of AWI and PWI also correlated strongly with CTFHC ( r = 0.73; p < 0.001). CT measurements of LCEA and AI were 3.4° less and 2.3° greater than radiological LCEA and AI measures. There was a linear relation between radiological LCEA and CT FHC. The linear regression model statistically significantly predicted FHC from LCEA, F(1,96) = 545.1 (p < 0.001), adjusted R2 = 85.0%, with the prediction equation: CT FHC(%) = 42.1 + 0.77(XRLCEA) Conclusion CT and roentgenographical measurement of acetabular parameters are comparable. Currently, a radiological LCEA greater than 25° is considered normal. This study demonstrates that those with hip pain and normal radiological acetabular parameters may still have deficiencies in FHC. More sophisticated imaging techniques such as 3D CT should be considered for those with hip pain to identify deficiencies in FHC. Cite this article: Bone Jt Open 2022;3(1):12–19.
COVID-19 potentially causes long-term deterioration of lung function: a systematic review and meta-analysis
Authors: Patria Yudha Nur , Sabirin Rahmaningsih Mara 
Published: January 2022

BACKGROUND The COVID-19 is an emerging disease that commonly involves respiratory complaints, including acute respiratory distress syndrome. The effect of COVID-19 on pulmonary function is still unclear and only based on sporadic reports with a small sample size. This study aimed to compile evidence on the pulmonary function of patients who have recovered from COVID-19.
METHODS Literature searching was conducted in PubMed, Embase, Google Scholar, Scopus, Web of Sciences, and CINAHL. Any types of studies published before June 26, 2020 and reported lung function tests of post-COVID-19 patients were included. Articles reporting data from early hospitalization were excluded. The risk of bias was measured using tools developed by the Joanna Briggs Institute. Meta-analysis was done using a meta statistical package in R and presented in the random effects model.
RESULTS 378 recovered COVID-19 patients in 7 studies were included. The lung function measurement periods were varied, ranging from 14 days after hospitalization to 10 weeks after receiving rehabilitation. Meta-analyses found that the pooled mean of diffusion capacity of carbon monoxide in recovered COVID-19 patients was lower than 80% predicted, whereas the other parameters were normal. The forced vital capacity and total lung capacity showing restrictive lung disorders were significantly lower in the severe COVID-19 survivors.
CONCLUSIONS COVID-19 has a negative impact on lung function for at least several weeks in the recovery period. Diffusion and restrictive problems could be the main long-term consequences of COVID-19.
PMMA-doped composite films microlens arrays on a flexible substrate for improving extraction of an organic light-emitting diode
Authors: Zhang Xuehua , Xie Jingwei , Zhang Yaqi , Sun Rui , Liu Shun , Zhang Wei , Zhang Xinwen , Hu Fangren 
Published: January 2022

Poly (methyl methacrylate) (PMMA)-doped organic-inorganic composite films are prepared on flexible substrates through a combination of the sol-gel technique and the spin-coating method. Circular and hexagonal microlens arrays (MLAs) are then built into the composite films by using ultraviolet nanoimprint technology. Atomic force microscope and ultraviolet spectrophotometer characterization results of the films show that the films have low surface roughness and good optical transmittance. A scanning electron microscope is used to observe the surface morphology of the MLAs, and the results show that the prepared MLAs are regular and neat. The surface profiles of the MLAs are also measured by using a surface profiler. Optical microscopy results show that the prepared MLAs have good optical imaging properties. Finally, the MLAs are applied on the green organic light-emitting diodes (OLEDs), and the influence of the shape and diameter of the MLAs on the luminance and current efficiency of the OLEDs is discussed. Results indicate that there is a relatively high enhancement of the current efficiency and luminance for the OLEDs with hexagonal MLAs and a single microlens height of 9 µm, where the luminance can reach

10611

c
d

/

c

m

2

, and the current efficiency can be enhanced by about 20.1%. Furthermore, there is a higher enhancement of the luminance and current efficiency for the OLEDs with PMMA-doped MLAs than that of the OLEDs with no PMMA-doped MLAs. Based on these results, we believe that the obtained PMMA-doped composite film MLAs on flexible substrates have important applications in the flexible OLEDs displays areas.